Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients.
Verkkoniemi-Ahola A, Hartikainen P, Hassi K, Kuusisto H, Lahdenperä S, Mehtälä J, Viitala M, Ylisaukko-Oja T, Soilu-Hänninen M. Verkkoniemi-Ahola A, et al. Among authors: kuusisto h. Mult Scler J Exp Transl Clin. 2023 Oct 4;9(4):20552173231204466. doi: 10.1177/20552173231204466. eCollection 2023 Oct-Dec. Mult Scler J Exp Transl Clin. 2023. PMID: 37808458 Free PMC article.
Multiple sclerosis in Finland 2018-Data from the national register.
Laakso SM, Viitala M, Kuusisto H, Sarasoja T, Hartikainen P, Atula S, Tienari PJ, Soilu-Hänninen M. Laakso SM, et al. Among authors: kuusisto h. Acta Neurol Scand. 2019 Nov;140(5):303-311. doi: 10.1111/ane.13145. Epub 2019 Jul 29. Acta Neurol Scand. 2019. PMID: 31271648
Corrigendum to "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation" [Multiple Sclerosis and Related Disorders 38 (2020) 101498].
Mustonen T, Rauma I, Hartikainen P, Krüger J, Niiranen M, Selander T, Simula S, Remes AM, Kuusisto H. Mustonen T, et al. Among authors: kuusisto h. Mult Scler Relat Disord. 2020 Jun;41:102107. doi: 10.1016/j.msard.2020.102107. Epub 2020 Apr 18. Mult Scler Relat Disord. 2020. PMID: 32571611 No abstract available.
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients.
Rauma I, Mustonen T, Seppä JM, Ukkonen M, Männikkö M, Verkkoniemi-Ahola A, Kartau M, Saarinen JT, Luostarinen L, Simula S, Ryytty M, Ahmasalo R, Sipilä JOT, Pieninkeroinen I, Tapiola T, Remes AM, Kuusisto H. Rauma I, et al. Among authors: kuusisto h. J Neurol. 2022 Feb;269(2):824-835. doi: 10.1007/s00415-021-10664-w. Epub 2021 Jul 13. J Neurol. 2022. PMID: 34255182 Free PMC article.
67 results